In the subcutaneous tumor model, lymphocytes from mice treated with the combination of DCs[SC] and M-HIFU demonstrated enhanced lysis of OLFM4-positive target cells, which was further amplified by combined treatment with DCs[SC] (Figure 2d). Here, OLFM4 is linked to neoplasm.